MedPath

Ultrasound guided Erector spinae plane block with Versus without Clonidine for perioperative breast analgesia.

Not yet recruiting
Conditions
Malignant neoplasm of central portion of breast,
Registration Number
CTRI/2020/12/029557
Lead Sponsor
pgimer
Brief Summary

This study will assess the significance of adding clonidine to the anesthetic mixture for women undergoing breast surgery under ESPB in terms of opioid and other analgesic consumption. secondary objectives were to  assess pain scores, perioperative hemodynamic stability , return to daily activity.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • ASA grade I-II healthy Adults 2.
  • Patients above the age of 18 years to 65 years 3.
  • Patients who can understand the VAS scale.
Exclusion Criteria
  • Patient refusal to participate 2.
  • Patient unable to co-operate 3.
  • Local sepsis at the site of block 4.
  • Coagulability/ patient on anti-coagulants 5.
  • Known hypersensitivity to local anaesthetics or morphine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of opioid free analgesia of Erector Spinae Plane Block with local anesthetic alone versus local anesthetic mixture with added clonidine for perioperative pain relief in patients undergoing Breast surgeries00 hours, 02 hours, 06 hours, 12 hours, 24 hours
Secondary Outcome Measures
NameTimeMethod
1.To compare the total rescue opioid or opioid equivalent drugs required in the first 24 hours after surgery.2.To compare the complications associated with the this regional anaesthetic technique.

Trial Locations

Locations (1)

nehru hospital, ot complex, 4th floor, general surgery ot

🇮🇳

Chandigarh, CHANDIGARH, India

nehru hospital, ot complex, 4th floor, general surgery ot
🇮🇳Chandigarh, CHANDIGARH, India
dr kulbhushan saini
Principal investigator
9968856948
kulbhushansaini007@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.